 Antares Pharma Inc NASDAQ: ATRS has nabbed another FDA approval, and the Companys second involving testosterone. The Company announced FDA approval for Tlando testosterone undecanoate, an oral treatment for testosterone replacement therapy indicated for deficiency or absence of. 